In olfactory bulbectomized rats, a validated model of MDD (Song and Leonard, 2005), chronic fluoxetine treatment reduced depressive-like behavior in the open-field test, and reduced c-fos expression in the Pa, amygdala, hippocampus, and DR nucleus (Roche et al., 2007). This evidence concerns the gene FOS and major depressive disorder.